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Golgi membranes and Golgi-derived vesicles are asso-
ciated with multiple cytoskeletal proteins and motors,
the diversity and distribution of which have not yet
been defined. Carrier vesicles were separated from
Golgi membranes, using an in vitro budding assay, and
different populations of vesicles were separated using
sucrose density gradients. Three main populations of
vesicles labeled with b-COP, g-adaptin, or p200/myosin
II were separated and analyzed for the presence of ac-
tin/actin-binding proteins. b-Actin was bound to Golgi
cisternae and to all populations of newly budded vesi-
cles. Centractin was selectively associated with vesicles
co-distributing with b-COP-vesicles, while p200/myosin
II (non-muscle myosin IIA) and non-muscle myosin IIB
were found on different vesicle populations. Isoforms of
the Tm5 tropomyosins were found on selected Golgi-
derived vesicles, while other Tm isoforms did not colo-
calize with Tm5 indicating the association of specialized
actin filaments with Golgi-derived vesicles. Golgi-de-
rived vesicles were shown to bind to F-actin polymer-
ized from cytosol with Jasplakinolide. Thus, newly bud-
ded, coated vesicles derived from Golgi membranes can
bind to actin and are customized for differential inter-
actions with microfilaments by the presence of selective
arrays of actin-binding proteins.
Protein trafficking into and out of the Golgi complex requires
multiple populations of membrane-bound vesicles or tubules.
Each vesicle population is associated with distinct sets of coat
complexes, G proteins, and SNARE proteins designed to ensure
the selective trafficking of cargo proteins. The Golgi complex is
also associated with diverse cytoskeletal elements, and Golgi-
derived vesicles must, it now appears, carry multiple molecular
motors in order to interact with different cytoskeletal struc-
tures (1, 2). Microtubules and microtubule-based motors par-
ticipate in positioning of the Golgi complex within the cell and
in vesicular transport between the endoplasmic reticulum and
Golgi as well as in some post-Golgi pathways (3). Elements of
the actin cytoskeleton are also involved in Golgi trafficking.
The p200/myosin II protein, analogous to the heavy chain of
nonmuscle myosin IIA, binds specifically to vesicles budding off
the trans-Golgi network (TGN)1 in many cells (4–7). Brush
border myosin I has been localized to Golgi membranes, vesi-
cles, and secretory granules (8–11). Dynactin and myosin I are
found on the same carrier vesicles budding off the TGN in
epithelial cells (11). Myosin 5a can interact with actin as well
as with microtubules (12), and diverse roles, ranging from
synaptic vesicle transport (13) to the movement of smooth
endoplasmic reticulum and pigment granules, have been pro-
posed for myosin 5a (14). Recent studies show that some iso-
forms of cytoskeletal proteins associate uniquely with the
Golgi, suggesting that the Golgi has its own, dedicated cy-
toskeleton. A Golgi-specific kinesin-like protein (Rab-kinesin;
Ref. 15), a Golgi-specific isoform of spectrin (16), and two iso-
forms of ankyrin that are concentrated on the Golgi complex
(17, 18) have been identified.
The potential roles of actin filaments and their associated
proteins in either maintaining Golgi structure or in vesicular
trafficking are not well understood. In most cells the Golgi
complex is closely aligned with the microtubule-organizing cen-
ter, but such a morphologically distinct, stable connection to
the Golgi complex is not evident for microfilaments. The asso-
ciation of actin and actin-binding proteins with Golgi mem-
branes might therefore be more dynamic. The use of actin-
polymerizing or -depolymerizing drugs has served to generally
implicate the actin cytoskeleton in vesicular trafficking, espe-
cially in endocytic pathways in intact cells (19, 20). Secretory
yeast mutants have provided the most direct evidence for a
requirement for actin in vesicular transport. The temperature-
sensitive mutant of Myo2p, a myosin V gene product of the
yeast Saccharomyces cerevisiae, has defective post-Golgi trans-
port and accumulates vesicles destined for the vacuole and for
exocytosis (21–25). Mutation of the Act-1 genes in yeast block
secretion (26). These studies demonstrate that the actin cy-
toskeleton, at some level, does participate in vesicle trafficking,
but specific roles for actin in various stages of vesicle budding,
transport, or targeting remain unknown.
Proteins participating in vesicular transport interact with
highly specific membrane domains, either on cisternal mem-
branes in different parts of the Golgi stack or on selected
vesicles. The distribution of individual proteins thus often in-
dicates their sites of action in different pathways or steps of
vesicle transport. The current study was undertaken to deter-
mine the distributions of actin and actin-associated proteins
with Golgi membranes and with Golgi-derived vesicles. Using
an in vitro assay to generate different populations of Golgi-
derived vesicles, we have analyzed the distinct arrays of actin,
myosins II, tropomyosin isoforms, and other proteins associ-
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ated with different membrane domains. Probably through the
actions of one or more of these proteins, newly budded vesicles
have the ability to bind to actin filaments.
EXPERIMENTAL PROCEDURES
Antibodies—The monoclonal antibody (mAb) AD7, which recognizes
p200/myosin II, has previously been characterized (4). Three antibodies
were used to detect tropomyosin isoforms; the CG3 mAb raised against
a peptide encoded by the TmNM5 gene (27) reacts with its Tm5NM-1,
-2, -3, and -4 isoforms. A subset of these isoforms (Tm5NM-1 and 2) is
more specifically recognized by the WS5/9d antibody raised against the
product of the 9d exon (28). The polyclonal af9d antiserum recognizes
Tms 2, 3, 5a, and 5b encoded by the aTmfast gene and Tm1 from the
b-Tm gene (29). The g-adaptin antibody was a kind gift from Dr. M. S.
Robinson (University of Cambridge, Cambridge, United Kingdom).
mAbs against b-COP, an antibody against the 58-kDa peripheral Golgi
protein, and a-smooth muscle actin were obtained from Sigma. Myosin
IIA and IIB antibodies were a kind gift of Dr. R. S. Adelstein (National
Institutes of Health, Bethesda, MD). The p23 antibody was provided by
Dr. J. Gruenberg (University of Geneva, Geneva, Switzerland), the
syntaxin 6 antibody by Dr. D. James (University of Queensland, Bris-
bane, Australia), and the Rab 6 antibody by Dr. B. Goud (Institute
Curie, Paris, France). An antibody to rat dynamin I was from Trans-
duction Laboratories (Lexington, KY). Secondary antibody conjugates
were purchased from Vector Laboratories (Burlingame, CA).
Preparation of Golgi Membranes and Separation of Golgi-derived
Vesicles—Golgi-rich membranes were prepared from rat liver homoge-
nates using a procedure modified from Leelavathi et al. (30). Briefly, a
post-nuclear supernatant of homogenized rat liver was layered onto a
discontinuous sucrose gradient consisting of 2.5 ml of 1.3 M and 0.86 M
sucrose solutions overlaid with 2 ml of 0.25 M sucrose. The gradients
were centrifuged at 144,000 3 g for 70 min. The supernatant of the 0.5
M sucrose layer was collected as cytosol, and the band above the 0.86 M
sucrose interface was harvested as Golgi membranes. Snap-frozen cy-
tosol and membrane samples were re-ultracentrifuged prior to use.
An in vitro assay for vesicle budding was used (31–33). Washed Golgi
membranes (200 mg) were resuspended in HKM buffer (20 mM KCl, 2.5
mM magnesium acetate, 25 mM Hepes-KOH, pH 7.4) and preincubated
with 0.1 mM GTPgS for 5 min at 37 °C, after which precleared cytosol
(14 mg) was added and the reaction was continued for 30 min at 37 °C
in the presence of 0.5 mM dithiothreitol and an ATP-regenerating sys-
tem (4.6 IU/ml creatine phosphokinase, 81 mM creatine phosphate, and
28.6 mM ATP (disodium salt) in a 2-ml total volume). The reaction was
terminated by incubation for 10 min in an ice-water slurry. The rem-
nant (unbudded) Golgi cisternae were separated from the cytosol con-
taining free vesicles by differential centrifugation (17,500 3 g for 10
min at 4 °C). Vesicles were then separated from cytosol by discontinu-
ous sucrose gradient centrifugation on 200 ml of 2.1 M sucrose, overlaid
with 200 ml of 20% sucrose (w/w), and 2 ml of the cytosol/vesicle mixture
(100,000 3 g for 90 min at 4 °C). All sucrose solutions were prepared in
HKM buffer. The cytosol was collected from the loading zone, and the
budded vesicles were harvested at the 2.1 M/20% interface.
For vesicle separation, free vesicles were resuspended in a total
volume of 400 ml of 20% sucrose and layered onto a discontinuous
sucrose gradient consisting of 300 ml of each of the following sucrose
solutions: 50%, 45%, 40%, 35%, 30%, and 25% (w/w) (33). The gradient
was centrifuged for 18 h at 100,000 3 g at 4 °C. The isopycnic gradient
was fractionated from the bottom in 220-ml fractions by syringe punc-
ture. Fractions were analyzed by SDS-PAGE and immunoblotting.
F-actin Binding Assay—Rat liver cytosol was precleared by ultracen-
trifugation (100,000 3 g, 45 min, 4 °C), and aliquots (1 mg) were
incubated in vesicle budding assay buffer (HKM buffer) supplemented
with 0.5 mM dithiothreitol, 0.1 mM GTPgS, in the presence or absence of
5 mM MgATP at 37 °C for 45 min. Jasplakinolide (JAS, Molecular
Probes, Eugene, OR) was added at a final concentration of 1 mM to
polymerize/stabilize F-actin; we have shown previously that under
these conditions cytosolic G-actin is efficiently converted to F-actin (20).
F-actin was pelleted from the cytosol by low speed centrifugation
(17,500 3 g, 30 min, 4 °C), then washed in HKM buffer, and aliquots
representing 100% of the F-actin pellet and 10% of the remaining
cytosol supernatant were loaded onto SDS-PAGE gels and analyzed by
immunoblotting to identify proteins coprecipitated with F-actin.
To analyze binding of Golgi vesicles to F-actin, vesicle fractions
harvested from the vesicle separation gradient were diluted, ultracen-
trifuged (100,000 3 g), and resuspended in HKM buffer. F-actin, poly-
merized with JAS from cytosol, was prepared in the presence of MgATP,
to avoid saturation with soluble myosin II. Pelleted, washed F-actin was
resuspended and incubated with the vesicle fractions in the presence of
GTPgS for 30 min at 37 °C. F-actin was then repelleted by centrifuga-
tion at low speed, and the resulting pellets and supernatants were
analyzed by SDS-PAGE and immunoblotting to detect actin-bound ves-
icle-associated proteins and by electron microscopy to examine actin-
bound vesicles.
SDS-PAGE and Immunoblotting—Samples for SDS-PAGE were sep-
arated on 5–15% gradient gels (34). Proteins were transferred onto
Immobilon-P membrane in 15 mM Tris, 120 mM glycine, 20% methanol;
membranes were routinely stained with 0.1% Coomassie Brilliant Blue
R250 to check protein loading. For immunoblotting, transfers were
blocked in Blotto (20 mM Tris, 150 mM NaCl, 5% skim milk, 1% Triton
X-100), antibody incubations were carried out in Blotto for 1–2 h at
room temperature or overnight at 4 °C, and bound antibodies were
detected with alkaline phosphatase-conjugated secondary antibodies
with 5-bromo-4-chloro-3-indolyl phosphate/nitro blue tetrazolium or
with chemiluminescence.
Immunoelectron Microscopy—Golgi-enriched membranes and bud-
ded vesicles generated in the in vitro budding assay were fixed in 4%
paraformaldehyde in phosphate-buffered saline overnight at 4 °C, col-
lected on Formvar/carbon-coated copper grids by floating grids on 5-ml
drops of suspensions of fixed budded membranes for 5 min at room
temperature, then washed and stained with 1.8% methylcellulose con-
taining 0.4% uranyl acetate for 10 min on ice. Negative contrast of
whole mounts was obtained by staining with 1% uranyl acetate for 1
min and removal of excess stain with Whatman filter paper. Specimens
were examined in a Joel 1010 transmission electron microscope.
Immunofluorescence Staining—NIH 3T3 fibroblasts grown at 8000
cells/cm2 on poly-L-lysine substrate were serum-starved for 48 h, caus-
ing them to withdraw from the cell cycle into the G0 (quiescent) phase
of the cell cycle. Quiescent fibroblasts were fixed with 4% paraformal-
dehyde, permeabilized with chilled (220 °C) methanol, and then dou-
ble-immunostained with the WS5/9d antibody together with the 58K
antibody that detects a peripheral Golgi membrane protein and the
AD7 antibody. Goat anti-rabbit-conjugated lissamine rhodamine and
goat anti-mouse-conjugated fluorescein secondary antibodies were used
for detection. Staining patterns were analyzed by confocal scanning
laser microscopy (Wild Leitz Instruments, Heidelberg, Germany).
RESULTS
Budding and Separation of Golgi-derived Vesicles—In vitro
budding assays were performed using rat liver Golgi mem-
branes and cytosol in the presence of GTPgS. Vesicle budding is
demonstrated by the de novo membrane binding of two cytoso-
lic proteins, p200/myosin II and b-COP (Fig. 1). Small amounts
(,10%) of the coatomer protein b-COP and of p200/myosin II
are present on freshly isolated, washed Golgi membranes (Fig.
1). Newly budded vesicles were initially separated from rem-
nant cisternae and cytosol by centrifugation. The budded ves-
icle pellet is enriched in p200/myosin II and b-COP, compared
with the original Golgi membranes, showing that coated vesi-
cles have been generated during the assay and that these
cytosolic proteins have specifically bound to them (Fig. 1). Some
of the bound p200/myosin II and b-COP on the remnant Golgi
cisternae (Fig. 1) represents attachment to additional budding
sites or to budding vesicles that have not yet been released.
Golgi-derived vesicles were then separated on a second gra-
dient, and fractions were analyzed by immunoblotting and
densitometry to demonstrate the distribution of a range of
vesicle-associated proteins (Fig. 2). The distributions of three
proteins, p200/myosin II, b-COP, and g-adaptin, were found to
vary across the gradient (Fig. 2). Immunogold labeling has
previously confirmed that b-COP (as part of the coatomer or
COP I complex), g-adaptin (a component of AP-1 clathrin-
coated vesicles), and p200/myosin II are indeed localized on
separate vesicles (5, 35). Thus the overlapping, but neverthe-
less distinct, peak distributions of p200/myosin II, b-COP, and
g-adaptin correspond to different populations of vesicles (Fig.
2). b-COP has a broader distribution throughout the gradient
peaking at fractions F3–F7, and these same vesicles are labeled
for p23, an integral membrane protein of coatomer-coated ves-
icles and the cis-Golgi-network (36–39) (Fig. 2A). g-Adaptin
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peaks in fractions F4–F7, along with syntaxin 6, an integral
membrane protein in TGN-derived clathrin-coated vesicles (40)
(Fig. 2A). The peak distribution of p200/myosin II is in fractions
F1–F5, but as yet there is no endogenous transmembrane
marker with which to determine the identity of these vesicles.
To ensure that the protein pattern reflects the distribution of
membrane-bound proteins on vesicles in this gradient, the gra-
dient was loaded with 1 mg of precleared cytosol and run under
identical conditions. Soluble cytosolic proteins were found to
distribute in fractions F8–F10 (data not shown); in these frac-
tions, we are therefore unable to distinguish between vesicle-
bound and soluble proteins (Figs. 2A and 3B). However, pro-
teins in fractions F1–F7 were also analyzed on flotation
gradients and were confirmed as being membrane-bound (data
not shown). Thus, this gradient allows distinction and partial
separation of three Golgi-derived vesicle populations demarked
by the vesicle-associated proteins p200/myosin II, b-COP, and
g-adaptin.
Other vesicle-associated proteins were also detected on
newly budded vesicles (Fig. 2A). Dynamin was distributed
throughout the vesicle gradient and was not concentrated in
any one vesicle population. The dynamin antibody used can
recognize both dynamin I and dynamin II, and the two bands
appearing in these gels could represent two isoforms or splice
variants of dynamin. Rab 6, a monomeric G protein on Golgi
membranes, was identified in fractions F3–F8, corresponding
most closely to the distribution of b-COP labeled vesicles (Fig.
2A). Small amounts of Rab 4 were found in the gradient codis-
tributing with the peak g-adaptin-labeled vesicles and barely
detectable levels of Rab 5 were found in fractions toward the
top of the gradient. While the bulk of vesicles on this gradient
were generated from Golgi membranes, detection of these early
endosome-associated Rabs indicates a very small contamina-
tion by plasma membrane/early endosome derived vesicles,
possibly AP2 vesicles.
Actin and Actin-associated Proteins on Budded Vesicles—
The gradient separation of vesicle populations provided a basis
for analyzing the differential distribution of vesicle-associated
cytoskeletal proteins. By immunoblotting, it was noted that
b-actin was routinely present in fractions of Golgi membranes
and vesicles (Fig. 3A). While most of the b-actin is found in the
cytosol (Fig. 3, Table I), 7% of the b-actin present is on newly
isolated stacked Golgi membranes. We routinely found that
some of the total membrane-bound b-actin was lost to the
cytosol during the budding assay, possibly due to dissociation
or depolymerization of actin. However, some of the actin re-
FIG. 1. Cytosol and membrane fractions in the vesicle budding
assay. The budding reaction of Golgi-derived vesicles was monitored by
immunoblotting for p200/myosin II and b-COP, present in the cytosol
(lane 1) and in small amounts on isolated Golgi membranes (lane 2).
After budding, both proteins are in a combined cytosol and vesicle
fraction (lane 3) and some remained on remnant Golgi membranes (lane
4). Both proteins are found attached to vesicles (lane 6) after separation
from remnant cytosol (lane 5). Lanes 1, 3, and 5 represent 10% loading
of each fraction while lanes 2, 4, and 6 represent 100% of each pellet for
one budding reaction. The arrow denotes the 200-kDa p200/myosin II
band; a slower migrating band is sometimes recognized by the AD7
antibody (57). The lower panel shows the relative proportions of b-COP
and p200/myosin II in various fractions. A large excess of both proteins
is contributed by the cytosol, and #20% of both proteins is attached to
budding vesicles.
FIG. 2. Separation of Golgi-derived vesicles on sucrose density
gradients. A, vesicles from the budding reaction were separated by
gradient centrifugation and immunoblotting detected p200, b-COP,
p23, g-adaptin, syntaxin 6, dynamin, Rab 6, Rab 4, and Rab 5 in
fractions. The p200/myosin II and b-COP detected in F10 (loading zone)
most likely represent small amounts of remaining cytosol. B, p200/
myosin II, b-COP, and g-adaptin define distinct sets of vesicles; peak
distributions of each reveal the separation of three different vesicle
populations.
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mains bound to remnant cisternae and a consistent proportion
(3% of total) of the b-actin binds to the budded vesicles (Fig. 3,
Table I). b-Actin bound to all populations of vesicles and was
evenly distributed across all of the fractions of the vesicle
gradient (Fig. 3B). Each vesicle fraction contained approxi-
mately 0.3% of the total vesicle-associated b-actin. Centractin
was detected at low levels throughout the gradient but was
particularly concentrated in the b-COP-labeled vesicle popula-
tion (Fig. 3B), suggesting that it does bind preferentially to
these vesicles. p200/myosin II, which has been identified as
nonmuscle myosin IIA, is found on one of the TGN-derived
vesicle populations, and immunoblotting with an antibody
raised against the heavy chain of nonmuscle myosin IIA shows
a similar distribution peaking in fractions F1–F5, as expected.
In contrast, the nonmuscle myosin IIB isoform has a different
distribution, peaking in fractions F6–F8. The distribution of
membrane-bound myosin IIB overlaps with that of g-adaptin
vesicles, while some of the myosin IIB, in the higher fractions,
may also be cytosolic (Fig. 3B). These results now show that
more than one population of Golgi-derived vesicles is associated
with a member of the myosin II family and that myosin II
isoforms are targeted separately to specific vesicle-budding
membrane domains.
Tropomyosin isoforms were analyzed on Golgi membranes
and budded vesicles using two antibodies. Blotting with the
af9d antibody shows several low and high molecular mass
(30–38 kDa) isoforms of the aTmfast and b-TM gene families in
fractions at the top of the gradient, which may represent the
presence of cytosolic proteins (Fig. 3B). We found no evidence
for aTmfast and b-TM tropomyosins binding to Golgi mem-
branes before budding (data not shown) or to newly budded
vesicles (Fig. 3B). Probing with an antibody (CG3) that sees all
isoforms of the Tm5 gene family reveals a single band, which
could represent more than one isoform, and this was present in
both Golgi membrane and cytosol fractions. On the vesicle
gradient, the Tm5 band is seen in fractions at the top of the
gradient (F8–F9) which are likely to represent cytosolic Tm5,
and in fractions F1–F4, clearly representing Tm5 bound to
selected vesicles. Tm5 in these lower fractions of the gradient
coincides with the distribution of p200/myosin II-labeled vesi-
cle population (Fig. 3B).
In order to further investigate whether p200/myosin II and
Tm5 are colocalized on the same vesicles, or are on different
populations of co-migrating vesicles, immunostaining was car-
ried out with the AD7 antibody to p200/myosin II and with an
antibody (WS5/9d) that recognizes a subset of Tm5 gene prod-
ucts. Fig. 4 shows a quiescent 3T3 fibroblast labeled with the
58K antibody and the WS5/9d antiserum. Two isoforms
(Tm5NM-1 and -2) co-localize identically with the 58K Golgi
peripheral membrane protein in an asymmetric perinuclear
fashion. However, fibroblasts double-stained with p200/myosin
II (Fig. 4C) and WS5/9d (Fig. 4D) showed intense but mutually
exclusive perinuclear staining patterns, suggesting that Tm5
isoforms and p200/myosin II are enriched in different compart-
ments of the Golgi complex (Fig. 4, C and D, arrows). Compar-
ison of p200/myosin II staining with TGN38 showed that both
proteins colocalized and were enriched in the TGN (Fig. 4, E
and F, respectively). This suggests that at least some of the
Tm5 isoforms recognized by CG3 in the liver Golgi fractions are
on separate vesicles from p200/myosin II. These observations
demonstrate an actin-based structural complexity of the Golgi-
derived vesicle network, and suggest that specific microfila-
ment populations may have unique roles to play in Golgi
function.
Interaction of Actin-based Motor Proteins with F-actin—The
presence of actin and actin-binding proteins on Golgi-derived
vesicles led us to investigate whether individual vesicle-asso-
ciated proteins and the vesicles themselves could bind to actin
filaments (Figs. 5 and 6). Rat liver cytosol (100,000 3 g super-
natant) contained mostly G-actin, which was not pelleted by
low speed centrifugation (Fig. 5). When rat liver cytosol was
incubated with the actin-polymerizing drug JAS, 50% of the
total actin, detected with a general actin antibody, formed
F-actin, which could be pelleted at low speed. This F-actin was
then incubated with cytosol or with the newly budded vesicle
fractions to test the actin-binding properties of soluble proteins
(Fig. 5) and vesicles (Fig. 6), respectively. As an actin-based
FIG. 3. Distribution of actin and actin binding proteins. A,
b-actin was analyzed in fractions from the in vitro budding reaction by
immunoblotting. Lane 1, cytosol; lane 2, isolated Golgi membrane; lane
3, cytosol containing the budded vesicles; lane 4, remnant Golgi cister-
nae; lane 5, remnant cytosol; lane 6, total budded vesciles. Total budded
vesicles were separated from the remnant cytosol by ultracentrifuga-
tion on a sucrose step gradient. B, the distribution of actin and actin-
binding proteins in the vesicle gradient was determined by immuno-
blotting. Actin distributes evenly across the gradient. p200/myosin II
and myosin IIA are similarly in fractions F1–F5, while myosin IIB has
a different distribution (F5–F8). Centractin peaks in F3–F6 along with
b-COP. Tropomyosin isoforms recognized by the af9d antibody are
clustered in fractions F8 and F9, most likely representing a cytosolic
distribution. Tm5 tropomyosins recognized by CG3 are found in frac-
tions containing cytosol (F8 and F9) and are also in a specific vesicle
population (F1–F4).
TABLE I
Relative proportions of b-actin in assay fractions
A reproducible fraction of b-actin (7%) is bound to Golgi membranes
in isolated Golgi stacks (G). Most of the b-actin in the assay is present
in soluble form in the cytosol (C). Some of the membrane-bound b-actin
is present in total budded vesicles (P2, 3%) or remains on Golgi cister-
nae (P1). The amounts of b-actin in SDS-PAGE gel fractions were
analyzed by immunoblotting and densitometry. These data are repre-
sentative of three experiments. S1, cytosol 1 vesicles; S2, remnant
cytosol.
Fractions C G S1 P1 S2 P2
Total b-actin (%) 93 7 99 #1 96 3
Myosin Binding to Golgi Membranes10746
 at UQ Library on October 19, 2016
http://w
w
w
.jbc.org/
D
ow
nloaded from
 
motor, p200/myosin II in the cytosol would be expected to bind
to actin filaments; accordingly, we found that 50% of the solu-
ble p200/myosin II in the cytosol was pelleted along with the
F-actin, under these conditions (Fig. 5). In control experiments,
neither the incubation buffer nor the addition of GTPgS to the
cytosol was sufficient to induce polymerization of F-actin or
pelleting of p200/myosin II (Fig. 5). This assay was also carried
out in the presence and absence of MgATP, which typically
dissociates motor proteins from actin (Fig. 6).While 50% of
p200/myosin II and myosin IIB bound to F-actin in the absence
of MgATP, both myosins II were liberated upon treatment with
MgATP, no longer appearing in the F-actin pellet (Fig. 6).
These data confirm that both p200/myosin II (myosin IIA) and
myosin IIB in the cytosol can associate with F-actin via their
head domains. In contrast, centractin (30%) was pelleted with
F-actin in a MgATP-independent fashion (Fig. 6). Tm5 tropo-
myosins also bound to F-actin in this assay, and this binding
was slightly reduced in the presence of MgATP (Fig. 6).
As controls, we also tested whether other cytosolic, vesicle-
associated proteins, which are not known to bind actin, could be
pelleted with F-actin. Soluble forms of b-COP and g-adaptin
did not pellet in significant amounts in either the presence or
absence of MgATP and therefore did not bind specifically to
F-actin (Fig. 6). We also found that, under these conditions,
cytosolic dynamin, in its GTP-bound form in the presence of
GTPgS, did not bind appreciably to F-actin (Fig. 6).
Golgi-derived Vesicle Populations Associate with F-actin—
Having confirmed that some of the vesicle-associated proteins
have the ability to bind to F-actin, we next investigated
whether intact, newly budded vesicles themselves could bind to
F-actin (Figs. 7 and 8). Actin was polymerized with JAS from
rat liver cytosol, in the presence of MgATP to avoid saturation
of F-actin with soluble motors such as p200/myosin II, and the
F-actin was then pelleted at low speed (Fig. 7, P1). Vesicles
were collected from separated fractions of the vesicle separa-
tion gradient. In order to initially collect vesicles, the sucrose
concentration was reduced, but this did not release any of the
membrane-bound b-COP or p200/myosin II (Fig. 7, S2). The
vesicles were resuspended and incubated with cytosol contain-
ing F-actin in the presence of GTPgS (to avoid loss of vesicle
coats) in the absence of MgATP, and F-actin was then pelleted
FIG. 4. Tm5NM-1 and -2 do not colocalize with p200/myosin II
in fibroblasts. Quiescent NIH 3T3 fibroblasts were double-labeled by
immunofluorescence with antibodies to p200/myosin II, Tm5 isoforms,
and Golgi markers and analyzed by confocal microscopy. The staining
comparisons shown are within the same optical section. Panels A and B,
cells labeled with the 58K protein antibody and the WS5/9d antibody,
respectively, show identical Golgi staining. Panels C and D, cells
stained with the AD7 antibody and the WS5/9d antibody, respectively,
show different staining patterns in the Golgi area. Panels E and F, cells
stained with antibodies to p200/myosin II as TGN38, respectively, show
the same staining over the TGN and analyzed by confocal microscopy.
Thus, Tm5NM-1 and -2, recognized by the WS5/9d antibody, colocalize
with the 58K protein but not with p200/myosin II in the Golgi region.
FIG. 5. Binding of p200/myosin II to F-actin. Figure shows p200/
myosin II and actin in fractions of cytosol (C). Cytosol was incubated
with or without GTPgS and JAS as indicated; resulting F-actin was
recovered by low speed centrifugation, and the actin pellets (P) and
supernatants (S) were analyzed by immunoblotting. p200/myosin II is
in the supernatants and is only co-sedimented with F-actin produced by
JAS (P). S, supernatant, 10% loading of total fraction on gel; P, pellet,
100% loading on gel.
FIG. 6. Binding of cytosolic proteins to F-actin. Cytosol was
incubated with JAS in the presence and absence of MgATP. Pelleted
F-actin (P) and supernatants (S) were analyzed by immunoblotting.
Motor proteins (p200/myosin II and myosin IIB), centractin, b-actin,
and tropomyosin show significant amounts of sediment with F-actin (P)
whereas only insignificant amounts of b-COP, g-adaptin, and dynamin
pelleted with F-actin. The actin binding of p200/myosin II and myosin
IIB is dramatically reduced in the presence of MgATP. S*, supernatant,
10% of total fraction loaded on gel; P, pellet, 100% loading.
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at low speed under conditions that did not pellet vesicles alone.
Nearly all of the vesicles in fractions collected from the p200/
myosin II peak and the b-COP peak bound to the F-actin. Small
amounts of b-COP in the supernatant could be due to satura-
tion of F-actin binding for these vesicles or due to some uncoat-
ing of vesicles. In order to confirm that intact vesicles bind to
F-actin, the pelleted vesicles were also examined by electron
microscopy. Different types of intact, coated vesicles were iden-
tified in the budded vesicle fraction (Fig. 8, A–C). Coated ves-
icles and vesicle profiles were found in the F-actin pellet (Fig.
8D), and some vesicle profiles can be seen bound to actin
filaments (Fig. 8, D and E). Negative contrast of the F-actin/
vesicle pellet reveals superpolymerized F-actin (Fig. 8F, ar-
rows) as well as normal F-actin (Fig. 8F, arrowheads) around
vesicles. Taken together, these data show that newly budded
Golgi-derived vesicles can bind to F-actin, presumably through
the interaction of one or more of the actin-binding proteins
present on each vesicle population.
DISCUSSION
The budding assay described in this paper yields multiple
populations of intact, coated vesicles derived from Golgi mem-
branes (Fig. 9). When the full complement of vesicles was
further separated by gradient centrifugation, three distinct
populations were harvested and identified by the presence of
the vesicle-associated proteins p200/myosin II, b-COP, and
g-adaptin as markers. Each of these proteins from the cytosol
bound to Golgi membranes in a GTP-dependent fashion during
the budding assay, and each was then recovered in distinct
peak fractions of the vesicle separation gradient. The separa-
tion of these vesicles is consistent with results obtained by
immunoelectron microscopy showing that b-COP and p200/
myosin II (5) and g-adaptin and p200/myosin II (35) are on
separate populations of Golgi-derived vesicles. In addition,
there are undoubtedly other types of Golgi-derived vesicles
present. For instance, b-COP has also been found on non-
clathrin-coated vesicles budding off other parts of the Golgi
complex, including the TGN (41). Two other types of vesicles
that bud off the TGN are potentially also present within this
gradient: vesicles labeled with the p230 protein, which are
distinct from those bearing p200/myosin II (42); and those
defined by the AP-3 adaptor complex, which bud off the TGN
for transit to late endosomes and lysosomes (43). Our data also
suggest that fractions F1–F4 on the gradient contain separate
populations of vesicles labeled for either p200/myosin II or for
Tm5 isoforms.
Other proteins were found on one or more populations of
vesicles. The Rab family of monomeric G proteins bind to dif-
ferent classes of transport vesicles and commonly serve as
compartment markers. Rab 6 was found to codistribute with
b-COP, consistent with it being on vesicles involved in traffick-
ing in early parts of the Golgi stack, most likely those involved
in retrograde transport (44). Dynamin is a GTPase implicated
in the scission of clathrin-coated vesicles at the plasma mem-
brane (45, 46). Dynamin II has been localized on the TGN,
where it appears to be involved in the budding of at least two
vesicle populations: clathrin-coated vesicles and constitutive
secretory vesicles labeled for pIgA-R (47). Our data similarly
indicate a GTP-dependent binding of dynamin II to Golgi mem-
branes and additionally show that dynamin is distributed
across the whole gradient and is therefore associated with
multiple populations of vesicles and that dynamin does stay
attached to the membranes on newly budded vesicles after
their release. The presence of dynamin on all budded vesicles
suggests that it may form part of a generalized budding ma-
chinery, perhaps by aiding vesicle interactions with both mi-
crotubules and microfilaments, through binding to profilin and
amphiphysin (48, 49).
A dedicated spectrin/ankyrin network is assembled on Golgi
membranes (16, 18) and, although the functions of this network
are not yet understood, it has potential roles in maintaining
Golgi structure, in marshaling transmembrane proteins within
the plane of Golgi membranes and/or in vesicular transport
(50). Based on the equivalent spectrin structure at the plasma
membrane, it is reasonable to assume that short actin fila-
ments or actin-like molecules are also associated with the Golgi
complex. Centractin (ARP1) is an actin-related protein shown
to associate with spectrin on plasma membranes and on Golgi
membranes (51). Our data show that centractin is on newly
budded vesicles and, unlike actin itself, it is concentrated on
COP I vesicles. As part of the dynactin complex (52), centractin
has the potential to link Golgi membranes or vesicles with
microtubules. COP I vesicles are known to associate with mi-
crotubules (53) and have recently been shown to associate with
spectrin/ankyrin (50), suggesting several possible roles for cen-
tractin on these vesicles. Our results also indicate that small
amounts of actin itself, as the b-actin isoform (,10%), is stably
associated with Golgi membranes and that some b-actin is
bound to budded vesicles. Unlike the other vesicle-associated
proteins, b-actin was slightly de-enriched in the budded vesicle
fraction compared with the Golgi stack, suggesting that rela-
tively more of the actin is retained on non-budding membrane
domains of Golgi cisternae. In addition, b-actin was present on
all newly budded vesicles and, when tested, vesicles from all
fractions appeared to be equally competent to bind to F-actin.
The presence of membrane-associated actin with both the Golgi
cisternae and with budding vesicles suggests that actin fila-
ments could be both a structural component of the Golgi stack
as well as participating in trafficking. By electron microscopy,
under normal conditions of the budding reaction, we did not
observe prominent actin filaments associated with budded ves-
icles. Polymerized actin produced in the presence of JAS could,
however, be seen associated directly with vesicles. Thus, actin
present on Golgi membranes and/or on vesicles under physio-
logical conditions may be composed primarily of short fila-
ments, or actin filaments may associate with the membranes
only transiently. Actin on budded vesicles could be transferred
from the donor Golgi membranes, or new short filaments could
FIG. 7. Golgi-derived vesicles bind to F-actin. Actin polymerized
from rat liver cytosol with JAS in the presence of MgATP shows little
binding of either soluble p200/myosin II or b-COP (P1). More than 90%
of these soluble proteins remain in the supernatant (S1; 10% loading)
upon pelleting F-actin by differential centrifugation (P1; see Fig. 6).
More than 90% of both proteins remain in the supernatants (S1; see
Fig. 6 for loading details). Golgi-derived vesicle fractions (F2–F3, p200
vesicles; and F4–F5, b-COP vesicles) from the sucrose density gradient
were diluted and recovered by ultracentrifugation. The resulting super-
natant (S2) and pellet (P2) show that p200/myosin II and b-COP remain
bound to the vesicles after resuspension. Resuspended fractions across
the gradient were incubated with F-actin; the F-actin was then recov-
ered by low speed centrifugation (P). Under these conditions, both
p200/myosin II and b-COP vesicles pelleted with F-actin. Small
amounts of b-COP remain in the supernatant (S). S, supernatant, 10%
loading of total fraction on gel; P, pellet, 100% loading.
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arise from local nucleation sites on the surface of vesicles.
Tropomyosins associate closely with actin filaments and
serve to regulate filament stability and length. Cells typically
express several types and isoforms of tropomyosins, and there
is growing evidence to show that specific isoforms can be dif-
ferentially localized on actin filaments throughout cells (54).
Tropomyosins of the Tm5 family, recognized by the CG3 anti-
body, were detected here on rat liver Golgi membranes and
were on at least one specific vesicle population. This correlates
well with the demonstration that Tm5NM-1 and Tm5NM-2
isoforms of the Tm5 family are localized on Golgi membranes in
fibroblasts, as shown by immunofluorescence. In contrast, tro-
pomyosins detected by the af9d antibody, were not found on
vesicles. These findings indicate that tropomyosin isoforms
mark specific populations of microfilaments associated with
discrete cellular subcompartments. It also provides compelling
evidence that these different filament populations have specific
cellular functions (55). Actin filament heterogeneity may be
regulated throughout cells and even within the Golgi milieu by
the differential placement of tropomyosins associated with
membranes and vesicles. One of the two tropomyosin isoforms
in S. cerevisiae has been implicated in post-Golgi trafficking
(56) by the finding that temperature-sensitive mutants of the
TPM1 gene accumulate Golgi-derived transport vesicles. A
functional interaction of tropomyosin with a myosin V in this
pathway is further suggested, since the TPM1 gene shows
synthetic lethality with the MYO2 gene (56). An important role
of tropomyosins in vesicle trafficking could potentially be to
liaise with myosin motors in coordinating filament stability
and vesicle movement.
Myosins of multiple families appear in association with Golgi
membranes and on newly budded vesicles in cells (1, 35). p200/
myosin II is homologous to the heavy chain of non-muscle
myosin IIA (MHCIIA) and is on a specific subset of TGN-
derived vesicles (35, 57). It is interesting to note that non-
muscle myosin IIB is on different Golgi-derived vesicles. In
several cell types, nonmuscle myosins IIA and IIB have been
found on distinct membrane domains and have been ascribed to
different cellular functions such as cytokinesis and cell motility
(58, 59). The current data, however, provide the first indication
that both non-muscle myosin II isoforms could be involved in
trafficking and that there is highly specific targeting of each
protein to distinct vesicle-budding domains of Golgi mem-
branes. Myosin I is also found on vesicles budding off Golgi
membranes, where it is proposed to provide motor activity for
vesicle movement along actin filaments at the cell periphery
(10). The non-muscle myosins IIA and B, both in the cytosol
FIG. 8. Golgi-derived vesicles and F-
actin-bound vesicles. Vesicles budded
from rat liver Golgi membranes (Fig. 1,
lane 6) and Golgi-derived vesicles bound
to F-actin were examined as whole
mounts by transmission electron micros-
copy. The total vesicle population con-
tains coated vesicles of distinct appear-
ance and size (A–C). Vesicles with typical
clathrin coats (A and B) and smaller coats
(C) were recognized. Intact coated vesicles
(arrowhead) were recovered in the F-actin
pellet (D). Actin filaments (arrows) could
be seen in these samples, often aligned
with vesicles (D and E). Negative contrast
of whole mounts reveals the association of
different lipid vesicles with fine actin fil-
aments (arrowheads) as well as with long,
superpolymerized F-actin (arrows, F).
Scale bar, 200 nm.
FIG. 9. Schematic summary of cytoskeletal proteins associated
with different vesicles. Different Golgi-derived vesicle populations,
depicted as budding profiles, are distinguished by the presence of dif-
ferent cytoskeletal proteins and vesicle markers. F-actin is associated
with all newly budded vesicles. Myosins IIA and B, and Tm5 are,
however, found on distinct vesicles consistent with there being custom-
ized or unique actin filaments on different vesicle populations. It has
been shown that coating actin with different Tm isoforms has the
demonstrated potential to influence the specificity of their interaction
with different myosin isoforms (61).
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and on vesicles, are oriented for actin binding in a MgATP-de-
pendent motor-like configuration. p200/myosin II binds to the
vesicles in a GTP-dependent fashion during budding, and it
dissociates from vesicles soon after budding,2 suggesting it may
function only in the locale of the Golgi. However, there are
conflicting reports about whether p200/myosin II is an essen-
tial participant in the vesicle budding reaction (6, 60). Thus, as
with actin/membrane interfaces in other parts of the cell, the
surfaces of Golgi-derived vesicles appear to harbor multiple
classes of motors, perhaps for a series of temporal interactions
with microfilaments. Possible mechanisms for binding vesicles
to actin filaments, and their associated proteins, include direct
binding via myosins I or II or indirect association of actin with
the vesicle surface through spectrin/ankyrin assemblies. Mem-
brane binding through any of the known mechanisms for ves-
icle-associated proteins, for instance through different actions
of ARF-GTP (50), is likely to result in dynamic or temporary
binding of microfilaments to vesicles.
These data add to the emerging evidence that the Golgi
complex is associated with the actin cytoskeleton through mul-
tiple families of actin-binding proteins or actin-based motors.
Moreover, we show that specific isoforms or members of these
families are placed strategically and specifically on specific
membrane domains, or on specific vesicle populations. The
binding of specific isoforms of Tm5 tropomyosins to selected
vesicles suggests a mechanism for customizing actin filament
stability during vesicle budding or trafficking. Isoforms of my-
osin II on different vesicles could also provide for different
motor activity, vesicle movement, or attachment to actin fila-
ments during budding. A key issue to now resolve is how
individual actin-binding proteins and actin filaments bind to
vesicles and the relationships of these proteins during budding
or subsequent trafficking.
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